Affluent Partners Holdings' (HKG:1466) subsidiary Beijing Baijin Biotechnology agreed to cooperate with Hangzhou Changwei Hospital to establish a smart medical service model with specialized expertise and treatment, a Wednesday filing with the Hong Kong Exchange said.
The parties will utilize their complementary advantages to create a smart medical service system which will cover medical treatment, teaching, and scientific research.
The service model will include a smart medical information system, specialty and disease-based treatment and management smart medical service platforms, and a specialty-specific smart medical management system.
The Jewelry maker and trader's shares were up 14% on Wednesday's close.
Price (HKD): $0.57, Change: $+0.070, Percent Change: +14.00%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。